Skip to main content
SpringerLink
Log in

Nierenbeteiligung bei System- und Stoffwechselerkrankungen

  • Chapter
  • First Online:
Pathologie

Part of the book series: Pathologie ((PATHOL))

  • 6077 Accesses

Zusammenfassung

Das Kapitel behandelt die Nierenveränderungen, die sich im Zusammenhang mit systemischen Erkrankungen wie der Amyloidose oder dem Lupus erythematodes und Stoffwechselerkrankungen wie dem Diabetes mellitus einstellen und zu schweren Nierenschäden führen können. Für alle diese Erkrankungen werden die diagnostischen Besonderheiten eingehend in Text und Bild und teilweise auch tabellarisch dargestellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 469.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Alpers CE, Kowalewska J (2008) Fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 19:34–37

    PubMed  Google Scholar 

  2. Alpers CE, Smith KD (2008) Cryoglobulinemia and renal disease. Curr Opin Nephrol Hypertens 17:243–249

    PubMed  Google Scholar 

  3. Ault BH (2000) Factor H and the pathogenesis of renal diseases. Pediatr Nephrol 14:1045–1053

    CAS  PubMed  Google Scholar 

  4. Austin HA 3rd et al (1984) Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25:689–695

    PubMed  Google Scholar 

  5. Bagavant H, Fu SM (2009) Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol 21:489–494

    PubMed Central  CAS  PubMed  Google Scholar 

  6. Barbour T et al (2012) Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant 27:2673–2685

    PubMed Central  CAS  PubMed  Google Scholar 

  7. Benz K, Amann K (2010) Thrombotic microangiopathy: new insights. Curr Opin Nephrol Hypertens 19:242–247

    PubMed  Google Scholar 

  8. Bergner R et al (2006) Proteinuria in diabetic patients – is it always diabetic nephropathy? Kidney Blood Press Res 29:48–53

    PubMed  Google Scholar 

  9. Bick RL (2002) Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost 8:1–31

    CAS  PubMed  Google Scholar 

  10. Bohle A et al On primary and secondary malignant nephrosclerosis (author’s transl). Klin Wochenschr 51:841–57

    Google Scholar 

  11. Bohle A et al (1977) Malignant nephrosclerosis in patients with hemolytic uremic syndrome (primary malignant nephrosclerosis). Curr Top Pathol 65:81–113

    CAS  PubMed  Google Scholar 

  12. Bridoux F et al (2002) Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int 62:1764–1775

    CAS  PubMed  Google Scholar 

  13. Brouet JC et al (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57:775–788

    CAS  PubMed  Google Scholar 

  14. Copelovitch L, Kaplan BS (2008) The thrombotic microangiopathies. Pediatr Nephrol 23:1761–1767

    PubMed  Google Scholar 

  15. Danchenko N, Satia JA, Anthony MS (2006) Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15:308–318

    CAS  PubMed  Google Scholar 

  16. Dember LM (2006) Amyloidosis-associated kidney disease. J Am Soc Nephrol 17:3458–3471

    CAS  PubMed  Google Scholar 

  17. Dember LM et al (2001) Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Ann Intern Med 134:746–753

    CAS  PubMed  Google Scholar 

  18. Doria A (2010) Genetics of diabetes complications. Curr Diab Rep 10:467–475

    PubMed Central  CAS  PubMed  Google Scholar 

  19. Dronavalli S, Duka I, Bakris GL (2008) The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 4:444–452

    CAS  PubMed  Google Scholar 

  20. Elkayam O et al (2002) Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab. Arthritis Rheum 46:2571–2573

    PubMed  Google Scholar 

  21. Fabry H (2002) Angiokeratoma corporis diffusum--Fabry disease: historical review from the original description to the introduction of enzyme replacement therapy. Acta Paediatr Suppl 91:3–5

    CAS  PubMed  Google Scholar 

  22. Faraggiana T, Churg J (1987) Renal lipidoses: a review. Hum Pathol 18:661–679

    CAS  PubMed  Google Scholar 

  23. Feldman CH et al (2013) Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000–2004. Arthritis Rheumatism 65:753–763

    PubMed Central  PubMed  Google Scholar 

  24. Ferri C et al Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest 23:399–405

    Google Scholar 

  25. Ferri C et al (2004) Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33:355–374

    PubMed  Google Scholar 

  26. Ferri C (2008) Mixed cryoglobulinemia. Orphanet J Rare Dis 3:25

    PubMed Central  PubMed  Google Scholar 

  27. Fogo A, Qureshi N, Horn RG (1993) Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy. Am J Kidney Dis 22:367–377

    CAS  PubMed  Google Scholar 

  28. Forbes JM et al (2003) The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J 17:1762–1764

    CAS  PubMed  Google Scholar 

  29. Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446–1454

    CAS  PubMed  Google Scholar 

  30. Fremeaux-Bacchi V et al (2008) Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112:4948–4952

    PubMed Central  CAS  PubMed  Google Scholar 

  31. Furst DE et al (2013) Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population. Lupus 22:99–105

    CAS  PubMed  Google Scholar 

  32. Garg AX et al (2003) Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290:1360–1370

    CAS  PubMed  Google Scholar 

  33. Gasser C et al (1955) Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr 85:905–909

    CAS  PubMed  Google Scholar 

  34. de Goicoechea Jorge E et al (2007) Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci USA 104:240–245

    Google Scholar 

  35. Haas M, Kaul S, Eustace JA (2005) HIV-associated immune complex glomerulonephritis with ″lupus-like″ features: a clinicopathologic study of 14 cases. Kidney Int 67:1381–1390

    PubMed  Google Scholar 

  36. Heilig CW et al (1995) Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802–1814

    PubMed Central  CAS  PubMed  Google Scholar 

  37. Herrera GA, Turbat-Herrera EA (2010) Renal diseases with organized deposits: an algorithmic approach to classification and clinicopathologic diagnosis. Arch Pathol Lab Med 134:512–531

    PubMed  Google Scholar 

  38. Herrera GA et al (2004) Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med 128:875–879

    PubMed  Google Scholar 

  39. Hoffmann F et al (2011) The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrol Dial Transplant 26:1634–1640

    PubMed  Google Scholar 

  40. Hopfer H, Wiech T, Mihatsch MJ (2011) Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type. Nephrol Dial Transplant 26:2877–2884

    PubMed  Google Scholar 

  41. Howie AJ et al (2008) Physical basis of colors seen in Congo red-stained amyloid in polarized light. Lab Invest 88:232–242

    CAS  PubMed  Google Scholar 

  42. Hutchinson L (2011) Hematology: Allografting offers better outcomes than autografting for patients with myeloma. Nat Rev Clin Oncol 8:386

    PubMed  Google Scholar 

  43. Hwu WL et al (2009) Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum Mutat 30:1397–1405

    PubMed Central  CAS  PubMed  Google Scholar 

  44. Ivanyi B (1990) Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med 114:986–987

    CAS  PubMed  Google Scholar 

  45. Jarva H et al (2004) The group B streptococcal beta and pneumococcal Hic proteins are structurally related immune evasion molecules that bind the complement inhibitor factor H in an analogous fashion. J Immunol 172:3111–3118

    CAS  PubMed  Google Scholar 

  46. Jefferson JA, Shankland SJ, Pichler RH (2008) Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int 74:22–36

    CAS  PubMed  Google Scholar 

  47. Joh K (2007) Pathology of glomerular deposition diseases. Pathol Int 57:551–565

    PubMed  Google Scholar 

  48. Johannes L, Mayor J (2010) Induced domain formation in endocytic invagination, lipid sorting, and scission. Cell 142:507–510

    CAS  PubMed  Google Scholar 

  49. Jones HB (1848) On a New Substance Occurring in the Urine of a Patient with Mollities Ossium. Philosophical Transactions of the Royal Society of London 138:55–62

    Google Scholar 

  50. Karmali MA et al (1985) The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151:775–782

    CAS  PubMed  Google Scholar 

  51. Kimmelstiel P, Wilson C (1936) Intercapillary Lesions in the Glomeruli of the Kidney. Am J Pathol 12:83–98

    PubMed Central  CAS  PubMed  Google Scholar 

  52. Koya D et al (1997) Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115–126

    PubMed Central  CAS  PubMed  Google Scholar 

  53. Lerner AB, Watson CJ (1947) Studies of cryoglobulins; unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci 214:410–415

    CAS  PubMed  Google Scholar 

  54. Lin J et al (2001) Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol 12:1482–1492

    CAS  PubMed  Google Scholar 

  55. Loirat C, Fremeaux-Bacchi V (2008) Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr Transplant 12:619–629

    CAS  PubMed  Google Scholar 

  56. Lorenz EC et al (2010) Renal failure due to combined cast nephropathy, amyloidosis and light-chain deposition disease. Nephrol Dial Transplant 25:1340–1343

    PubMed  Google Scholar 

  57. Mannik M et al (2003) Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 30:1495–1504

    PubMed  Google Scholar 

  58. Markowitz GS, D’Agati VD (2009) Classification of lupus nephritis. Curr Opin Nephrol Hypertens 18:220–225

    CAS  PubMed  Google Scholar 

  59. McClements BM et al (1991) Rapidly progressive obstructive jaundice due to Congo red negative amyloidosis. Ulster Med J 60:229–234

    PubMed Central  CAS  PubMed  Google Scholar 

  60. Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349:583–596

    CAS  PubMed  Google Scholar 

  61. Migeon BR (2008) X inactivation, female mosaicism, and sex differences in renal diseases. J Am Soc Nephrol 19:2052–2059

    PubMed  Google Scholar 

  62. Montseny JJ et al (1998) Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant 13:1438–1445

    CAS  PubMed  Google Scholar 

  63. Moschcowitz E (1952) An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries; an undescribed disease. Am J Med 13:567–569

    CAS  PubMed  Google Scholar 

  64. Mosnier JF et al (1991) Recurrence of Fabry’s disease in a renal allograft eleven years after successful renal transplantation. Transplantation 51:759–762

    CAS  PubMed  Google Scholar 

  65. Murea M et al (2010) Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation. Clin J Am Soc Nephrol 5:2373–2379

    CAS  PubMed  Google Scholar 

  66. Nasr SH et al (2012) Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies. Am J Kidney Dis 59:786–794

    PubMed  Google Scholar 

  67. Nasr SH et al (2003) IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy. Hum Pathol 34:1235–1241

    CAS  PubMed  Google Scholar 

  68. Nishi S et al (2008) New advances in renal amyloidosis. Clin Exp Nephrol 12:93–101

    CAS  PubMed  Google Scholar 

  69. Nochy D et al (1993) Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 8:11–19

    CAS  PubMed  Google Scholar 

  70. Noris M et al (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844–1859

    PubMed Central  CAS  PubMed  Google Scholar 

  71. Nowling TK, Gilkeson GS (2011) Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther 13:250

    PubMed Central  PubMed  Google Scholar 

  72. Obrig TG (2011) Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease. Toxins (Basel) 2:2769–2794

    Google Scholar 

  73. Onoue K et al (2011) Using imaging mass spectrometry to accurately diagnose Fabry’s disease. Circ J 75:221–223

    PubMed  Google Scholar 

  74. Ortega LM et al (2010) Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus 19:557–574

    CAS  PubMed  Google Scholar 

  75. Park MH et al (1986) Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 44:309–319

    CAS  PubMed  Google Scholar 

  76. Patel M et al (2006) The prevalence and incidence of biopsy-proven lupus nephritis in the UK: Evidence of an ethnic gradient. Arthritis Rheumatism 54:2963–2969

    PubMed  Google Scholar 

  77. Pernow J, Shemyakin A, Bohm F (2012) New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus. Life Sci 91:507–516

    CAS  PubMed  Google Scholar 

  78. Ponticelli C, Moroni G, Glassock RJ (2011) Recurrence of secondary glomerular disease after renal transplantation. Clin J Am Soc Nephrol 6:1214–1221

    PubMed  Google Scholar 

  79. Porubský S, Gröne EF, Gröne HJ (2010) Nierenbeteiligung bei Paraproteinämien. Nephrologe 5:483–493

    Google Scholar 

  80. Porubský S et al (2004) Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium. Am J Pathol 164:2175–2187

    PubMed Central  PubMed  Google Scholar 

  81. Porubský S et al. (2014) Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure. J Pathol 234:120–133

    Google Scholar 

  82. Porubský S et al (2014) Renal lipidosis in patients enrolled in a methadone substitution program. Arch Pathol Lab Med 138:689–693

    PubMed  Google Scholar 

  83. Pozzi C et al (2003) Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 42:1154–1163

    PubMed  Google Scholar 

  84. Raml A et al (2005) Congo red-negative light chain disease with intractable diarrhea. Internist (Berl) 46:447–451

    CAS  Google Scholar 

  85. Ramos-Casals M et al (2012) The cryoglobulinaemias. Lancet 379:348–360

    CAS  PubMed  Google Scholar 

  86. Randall RE et al (1976) Manifestations of systemic light chain deposition. Am J Med 60:293–299

    CAS  PubMed  Google Scholar 

  87. Rathore R, Coward RA, Woywodt A (2012) What’s in a name? Bence Jones protein. Clinical Kidney Journal 5:478–483

    PubMed Central  PubMed  Google Scholar 

  88. Rosenstock JL et al (2003) Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features. Kidney Int 63:1450–1461

    PubMed  Google Scholar 

  89. Ruiz-Irastorza G et al (2010) Antiphospholipid syndrome. Lancet 376:1498–1509

    CAS  PubMed  Google Scholar 

  90. Russell WJ et al (2001) Monoclonal light chain--mesangial cell interactions: early signaling events and subsequent pathologic effects. Lab Invest 81:689–703

    CAS  PubMed  Google Scholar 

  91. Sanders PW (2011) Light chain-mediated tubulopathies. Contrib Nephrol 169:262–269

    PubMed  Google Scholar 

  92. Sansonno D et al (2009) Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage. J Immunol 183:6013–6020

    PubMed Central  CAS  PubMed  Google Scholar 

  93. Schena FP, Gesualdo L (2005) Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16(1):30–33

    Google Scholar 

  94. Schwartz MM, Lewis EJ (1980) The quarterly case: nephrotic syndrome in a middle-aged man. Ultrastruct Pathol 1:575–582

    CAS  PubMed  Google Scholar 

  95. Schwartz MM, Korbet SM, Lewis EJ (2002) Immunotactoid glomerulopathy. J Am Soc Nephrol 13:1390–1397

    PubMed  Google Scholar 

  96. Seshan SV, Jennette JC (2009) Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications. Arch Pathol Lab Med 133:233–248

    PubMed  Google Scholar 

  97. Sethi S et al (2013) Laser Microdissection and Proteomic Analysis of Amyloidosis, Cryoglobulinemic GN, Fibrillary GN, and Immunotactoid Glomerulopathy. Clin J Am Soc Nephrol 8:915–921

    PubMed Central  CAS  PubMed  Google Scholar 

  98. Soni SS et al (2006) Non diabetic renal disease in type 2 diabetes mellitus. Nephrology (Carlton) 11:533–537

    Google Scholar 

  99. Spada M et al (2006) High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 79:31–40

    PubMed Central  CAS  PubMed  Google Scholar 

  100. Spinale JM et al (2013) Update on Streptococcus pneumoniae associated hemolytic uremic syndrome. Curr Opin Pediatr 25:203–208

    CAS  PubMed  Google Scholar 

  101. Stringer S et al (2011) Recent advances in the pathogenesis and management of cast nephropathy (myeloma kidney). Bone Marrow Res 493697:2011

    Google Scholar 

  102. Strom EH et al (1994) Light chain deposition disease of the kidney. Morphological aspects in 24 patients. Virchows Arch 425:271–280

    CAS  PubMed  Google Scholar 

  103. Suzuki D et al (1999) Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol 10:822–832

    CAS  PubMed  Google Scholar 

  104. Symmers WS (1952) Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy). Br Med J 2:897–903

    PubMed Central  CAS  PubMed  Google Scholar 

  105. Terrell DR et al (2005) The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost 3:1432–1436

    CAS  PubMed  Google Scholar 

  106. Tsai HM (2006) The molecular biology of thrombotic microangiopathy. Kidney Int 70:16–23

    PubMed Central  CAS  PubMed  Google Scholar 

  107. Tsakiris D et al (1996) Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry. Nephrol Dial Transplant 11(7):4–20

    PubMed  Google Scholar 

  108. Vasavada N, Agarwal R (2005) Role of oxidative stress in diabetic nephropathy. Adv Chronic Kidney Dis 12:146–154

    PubMed  Google Scholar 

  109. Vernon KA, Cook HT (2012) Complement in glomerular disease. Adv Chronic Kidney Dis 19:84–92

    PubMed  Google Scholar 

  110. Vitsky BH et al (1969) The hemolytic-uremic syndrome: a study of renal pathologic alterations. Am J Pathol 57:627–647

    PubMed Central  CAS  PubMed  Google Scholar 

  111. von Hutten H et al (2009) Prevalence and origin of amyloid in kidney biopsies. Am J Surg Pathol 33:1198–1205

    Google Scholar 

  112. Vrana JA et al (2009) Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 114:4957–4959

    CAS  PubMed  Google Scholar 

  113. Weening JJ et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250

    PubMed  Google Scholar 

  114. Wornle M et al (2006) Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168:370–385

    PubMed Central  PubMed  Google Scholar 

  115. Yamagishi S et al (2007) Molecular mechanisms of diabetic nephropathy and its therapeutic intervention. Curr Drug Targets 8:952–959

    CAS  PubMed  Google Scholar 

  116. Zarate YA, Hopkin RJ (2008) Fabry’s disease. Lancet 372:1427–1435

    CAS  PubMed  Google Scholar 

  117. Zheng XL, Sadler JE (2008) Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol 3:249–277

    PubMed Central  CAS  PubMed  Google Scholar 

  118. Zipfel PF, Heinen S, Skerka C (2010) Thrombotic microangiopathies: new insights and new challenges. Curr Opin Nephrol Hypertens 19:372–378

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zelluläre und Molekulare Pathologie, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Deutschland

    H.-J. Gröne Prof. Dr. med.

  2. Pathologisches Institut, Universitätsmedizin Mannheim, Theodor-Kutzer-Ufer 1–3, 68167, Mannheim, Deutschland

    Stefan Porubský PD Dr. med.

Authors
  1. Stefan Porubský PD Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H.-J. Gröne Prof. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefan Porubský PD Dr. med. .

Editor information

Editors and Affiliations

  1. Abt. Nephropathologie, Pathologisches Institut Universität Erlangen-Nürnberg, Erlangen, Germany

    Kerstin Amann

  2. Klinisches Institut für Pathologie, Medizinische Universität Wien Allg. Krankenhaus der Stadt Wien, Wien, Austria

    Renate Kain

  3. Konsultationszentrum für Pankreas- und Endokrine Tumoren, Institut für Pathologie, Ismaninger Str. 22, 81675, Technische Universität München Klinikum rechts der Isar, München, Germany

    Günter Klöppel

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Porubský, S., Gröne, HJ. (2016). Nierenbeteiligung bei System- und Stoffwechselerkrankungen. In: Amann, K., Kain, R., Klöppel, G. (eds) Pathologie. Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04566-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04566-0_11

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04565-3

  • Online ISBN: 978-3-642-04566-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation